These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19542737)

  • 1. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
    Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
    J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
    Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
    Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.
    Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y
    Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 Diabetic Patients with and without diabetic foot ulcers.
    Mehmet E; Zuhal E; Mustafa K; Soner S; Aslı T; Sevki C
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S30-3. PubMed ID: 26476487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
    Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F
    Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
    Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J
    Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
    Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
    Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.
    Roussos L; Ekström U; Ehle PN; Oqvist B; Floren CH
    Scand J Urol Nephrol; 2004; 38(6):504-10. PubMed ID: 15841787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Erdogan M; Karadeniz M; Eroglu Z; Tezcanli B; Selvi N; Yilmaz C
    Diabetes Res Clin Pract; 2007 Dec; 78(3):355-9. PubMed ID: 17681394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotyping in Egyptian diabetic nephropathy patients.
    Atta MI; Abo Gabal K; El-Hadidi K; Swellam M; Genina A; Zaher NF
    IUBMB Life; 2016 Jan; 68(1):58-64. PubMed ID: 26662731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients.
    Jiang Y; Ma L; Han C; Liu Q; Cong X; Xu Y; Zhao T; Li P; Cao Y
    J Diabetes Res; 2017; 2017():3560920. PubMed ID: 28326331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.
    Tarnow L; Stehouwer CD; Emeis JJ; Poirier O; Cambien F; Hansen BV; Parving HH
    Nephrol Dial Transplant; 2000 May; 15(5):625-30. PubMed ID: 10809802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo E gene polymorphism on development of diabetic nephropathy.
    Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
    Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE polymorphism and diabetic nephropathy.
    Araki S
    Clin Exp Nephrol; 2014 Apr; 18(2):230-3. PubMed ID: 24026386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
    Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
    J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the angiotensinogen M235T and APO E gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
    Reis KA; Ebinç FA; Koç E; Demirci H; Erten Y; Güz G; Derici UB; Bali M; Söylemezoğlu O; Arınsoy T; Sindel S
    Ren Fail; 2011; 33(5):469-74. PubMed ID: 21500980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
    Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
    Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.